Successful engraftment in reduced-intensity cord blood transplantation (CBT) as a salvage therapy for graft failure after primary CBT in adults [2]

Transplantation

Volumn 83, Issue 9, 2007, Pages 1281-1282

  Kawamori, Yuriko ^a   Yakushijin, Kimikazu ^a   Okamura, Atsuo ^a   Nishikawa, Shinichiro ^a   Minagawa, Kentaro ^a   Shimoyama, Manabu ^a   Yamamoto, Katsuya ^a   Katayama, Yoshio ^a   Matsui, Toshimitsu ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOSPORIN A; FLUDARABINE; GANCICLOVIR; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; BONE MARROW CELL; CASE REPORT; CHIMERA; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DRUG EFFECT; ENGRAFTMENT; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HLA MATCHING; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SALVAGE THERAPY; SHORT COURSE THERAPY; WHOLE BODY RADIATION;

ADULT; BLOOD DONORS; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; FEMALE; FETAL BLOOD; HUMANS; MALE; MIDDLE AGED; RETREATMENT; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 34248327280     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000260635.19245.65     Document Type: Letter

References (10)

1. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815.
2. Schoemans H, Theunissen K, Maertens J, et al. Adult umbilical cord blood transplantation: A comprehensive review. Bone Marrow Transplant 2006; 38: 83.
3. Brunstein CG, Wagner JE. Cord blood transplantation for adults. Vox Sang 2006; 91: 195.
4. Narimatsu H, Kami M, Miyakoshi S, et al. Graft failure following reduced-intensity cord blood transplantation for adult patients. Br J Haematol 2006; 132: 36.
5. Ohwada C, Nakaseko C, Ozawa S, et al. Second cord blood transplantation (CBT) with reduced-intensity conditioning for graft failure after the first CBT for AML. Bone Marrow Transplant 2004; 34: 999.
6. Shimada K, Narimatsu H, Morishita Y, et al. Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient. Bone Marrow Transplant 2006; 37: 787.
7. Bolwell B, Sobecks R, Pohlman B, et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant 2004; 34: 621.
8. Bornhauser M, Schuler U, Porksen G, et al. Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation. Transplantation 1999; 67: 499.
9. Kiehl MG, Schafer-Eckart K, Kroger M, et al. Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients. Transplant Proc 2002; 34: 2922.
10. Neumann F, Graef T, Tapprich C, et al. Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versushost disease prophylaxis after stem cell transplantation from HLA-identical siblings. Bone Marrow Transplant 2005; 35: 1089.